To hear about similar clinical trials, please enter your email below
Trial Title:
Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention
NCT ID:
NCT05524480
Condition:
Cancer Prevention
Conditions: Official terms:
Uterine Cervical Neoplasms
Conditions: Keywords:
Implementation Intervention
Cervical Cancer
Breast Cancer
HPV Vaccination
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
Twenty community health centers (CHCs) will be recruited and randomized to either the
SEMM-Dissemination and Implementation Assistance arm or the SEMM-Usual Implementation
Practice arm.
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Salud en Mis Manos - Dissemination and Implementation Assistance
Description:
The experimental arm will utilize the multi-component and multifaceted implementation
strategy, SEMM-DIA. This includes elements like 1) A program orientation session (virtual
or in-person), 2) Technical Assistance for implementers, such as SEMM Program Manager/
Coordinator and LHWs, 3) SEMM program materials (including LHW Training curriculum,
in-reach/ outreach materials, patient tracking forms), and 4) Virtual community support
(Project ECHO series).
Arm group label:
Salud en Mis Manos - Dissemination and Implementation Assistance
Other name:
SEMM-DIA
Intervention type:
Behavioral
Intervention name:
Salud en Mis Manos- Usual Implementation Practice
Description:
The control arm will undertake SEMM- Usual Implementation Practice, which includes
utilizing all existing SEMM program materials (MOPs, LHW Training Curriculum, etc.) which
will be shared with clinic staff in PDF form.
Arm group label:
Salud en Mis Manos - Usual Implementation Practice
Other name:
SEMM
Summary:
The proposed study will develop and test an implementation strategy called Salud en Mis
Manos-Dissemination and Implementation Assistance (SEMM-DIA) which is an
internet-accessible cross-platform that includes additional implementation support
strategies to increase the reach, effectiveness, and implementation of an evidence-based
breast and cervical cancer screening and HPV vaccination program for Latinas (SEMM).
Detailed description:
This study tests a multicomponent and multifaceted implementation strategy, SEMM-DIA and
serves as a model for developing other implementation strategies designed to build the
capacity of clinic leadership, intervention champions, and LHWs to plan, manage, and
deliver SEMM. Investigators will examine the effect of SEMM-DIA program implementation in
a randomized group trial comparing the impact of SEMM-DIA vs. SEMM- Usual Implementation
Practice on the reach, effectiveness, implementation, and cost-effectiveness of SEMM in
safety-net clinics.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
Organization inclusion criteria:
- Clinic or community health center (CHC) with LHWs serving Latina populations.
- Expressed intent to participate in the implementation of SEMM.
- Serve low-income populations with low or no-cost screening and vaccination.
- Provide comprehensive primary health care services.
SEMM Participant Inclusion criteria:
- Latinas who self-identify as Hispanic/Latina.
- Latinas who have at least one unmet breast or cervical cancer prevention need,
following Electronic Clinical Quality Measures.
- (1) Latinas aged 21-64 years who have not had a Pap test in the past 3 years, and
(2) Latinas aged 30-64 who have not had a HPV test in the past 5 years (CMS eCQM ID:
CMS124v9).
- (3) Latinas aged 51-74 years who have not had a mammogram in the past 2 years (CMS
eCQM ID: CMS125v9).
- (4) Latinas aged 18-26 years who have not initiated HPV vaccination.
- Note: Some women will have more than one unmet need (e.g., HPV vaccination and
pap test), so they will be included in more than one non-adherent group.
Exclusion Criteria:
Organization exclusion criteria:
- Clinics/Community Health Centers not located in Texas.
SEMM Participant Exclusion criteria:
- Latinas with a prior or current cancer diagnosis due to modified cancer screening
surveillance guidelines for cancer survivors.
Gender:
Female
Minimum age:
18 Years
Maximum age:
74 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
The University of Texas Health Science Center at Houston
Address:
City:
Houston
Zip:
77030
Country:
United States
Contact:
Last name:
Lara Savas, PhD
Phone:
713-500-9638
Email:
lara.staub@uth.tmc.edu
Contact backup:
Last name:
Angelita Alaniz, MPH
Email:
angelita.alaniz@uth.tmc.edu
Investigator:
Last name:
Maria E Fernandez, PhD
Email:
Principal Investigator
Start date:
February 2, 2024
Completion date:
September 30, 2024
Lead sponsor:
Agency:
The University of Texas Health Science Center, Houston
Agency class:
Other
Collaborator:
Agency:
Centers for Disease Control and Prevention
Agency class:
U.S. Fed
Source:
The University of Texas Health Science Center, Houston
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05524480